Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2003
06/26/2003WO2003052134A2 Oligonucleotides comprising intercalator pseudonucleotide(s) for detection of nucleic acids and mutants hereof
06/26/2003WO2003052133A2 Oligonucleotide analogues comprising intercalator pseudonucleotides
06/26/2003WO2003052132A2 Linear and hairpin oligonucleotide analogues comprising intercalator pseudonucleotides
06/26/2003WO2003052124A2 Screening method for agents useful in treating diabetes
06/26/2003WO2003052119A2 Transporters and ion channels
06/26/2003WO2003052118A2 Bgl4 beta-glucosidase and nucleic acids encoding the same
06/26/2003WO2003052117A2 Methods and products related to non-viral transfection
06/26/2003WO2003052115A2 Post-synthesis labeling of nucleic acids and uses thereof
06/26/2003WO2003052111A2 Cotton alpha-globulin promoter for seed-specific expression of transgenes
06/26/2003WO2003052110A2 Nucleic acid nematicides
06/26/2003WO2003052109A1 Method of increasing the transgene-coded biomolecule content in organisms
06/26/2003WO2003052108A2 Improved methods and means for delivering inhibitory rna to plants and applications thereof
06/26/2003WO2003052107A1 Expression vector containing the promoter comprised of fis binding sites, up element and core promoter
06/26/2003WO2003052106A1 Method of screening compounds
06/26/2003WO2003052105A1 Cellulase preparations containing reducing agent and method of processing fiber
06/26/2003WO2003052104A1 A reporter gene
06/26/2003WO2003052103A1 Membrane-associated glutathione-nonspecific prostaglandin e synthase
06/26/2003WO2003052102A1 Specific antibody for detecting bradeion
06/26/2003WO2003052101A1 Sample tracking using molecular barcodes
06/26/2003WO2003052099A2 Methods of parallel gene cloning and analysis
06/26/2003WO2003052098A2 Method for controlled induction of somatic mutations and use thereof in proteomics
06/26/2003WO2003052097A1 Potentiometric dna microarray, process for producing the same and method of analyzing nucleic acid
06/26/2003WO2003052095A2 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell
06/26/2003WO2003052094A2 Expression vector for the production of annexin v
06/26/2003WO2003052089A1 Disruption of the glutathione s-transferase-omega-1 gene
06/26/2003WO2003052086A1 Immune related neuronal receptors and therapeutic uses thereof
06/26/2003WO2003052083A2 Methods for the generation of proliferating and differentiating cell lines
06/26/2003WO2003052078A2 Insect g protein-coupled receptor genes and uses thereof
06/26/2003WO2003052075A2 Enzymes
06/26/2003WO2003052073A2 Novel corn event
06/26/2003WO2003052072A2 Antisense modulation of estrogen receptor alpha expression
06/26/2003WO2003052071A2 Intracellular generation of single-stranded dna
06/26/2003WO2003052067A2 Vector mediated organelle transfection
06/26/2003WO2003052065A2 Antisense modulation of b-cell associated protein expression
06/26/2003WO2003052064A2 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
06/26/2003WO2003052063A2 Simplified eukaryotic nitrate reductase
06/26/2003WO2003052062A2 Antisense modulation of cd36l1 expression
06/26/2003WO2003052059A2 Recombinant bovine thrombin
06/26/2003WO2003052057A2 Egvi endoglucanase and nucleic acids encoding the same
06/26/2003WO2003052056A2 Egviii endoglucanase and nucleic acids encoding the same
06/26/2003WO2003052055A2 Egvii endoglucanase and nucleic acids encoding the same
06/26/2003WO2003052054A2 Bgl5 beta-glucosidase and nucleic acids encoding the same
06/26/2003WO2003052052A2 Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
06/26/2003WO2003052051A2 Adeno-associated virus (aav) serotype 8 sequences
06/26/2003WO2003052050A2 P450 enzymes, nucleic acids encoding them and methods of making and using them
06/26/2003WO2003052049A2 Molecules for disease detection and treatment
06/26/2003WO2003052048A2 Nucleic acid-associated proteins
06/26/2003WO2003051928A1 Antibody specific for detection of bradeion
06/26/2003WO2003051927A2 Production of f(ab')2 fragments in mammalian cells
06/26/2003WO2003051926A2 Anti-cd7 immunotoxin as fusion protein
06/26/2003WO2003051925A1 Human secretin-type gpcr (latrophilin)
06/26/2003WO2003051923A2 Novel g-protein coupled receptors and dna sequences thereof
06/26/2003WO2003051922A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor
06/26/2003WO2003051921A1 Chemokine mutants acting as chemokine antagonists
06/26/2003WO2003051920A1 A method for inducing apoptosis
06/26/2003WO2003051917A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
06/26/2003WO2003051915A1 A modulation protein with apoptosis coronary heart disease
06/26/2003WO2003051914A2 Ides, an igg-degrading enzyme of streptococcus pyogenes
06/26/2003WO2003051912A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
06/26/2003WO2003051905A2 Taojiks as modifiers of the beta-catenin pathway and methods of use
06/26/2003WO2003051901A2 Pseudonucleotide comprising an intercalator
06/26/2003WO2003051834A2 Immunocellular receptors related to neurological disorders
06/26/2003WO2003051832A2 Histamine h2 receptor and uses
06/26/2003WO2003051520A1 Centrifugal spectrometer
06/26/2003WO2003051483A1 Method and device for isolating and purifying a polynucleotide of interest on a manufacturing scale
06/26/2003WO2003051454A2 Methods for particle-assisted polynucleotide immunization using a pulsed electric field
06/26/2003WO2003051402A1 Adenoviral vector containing cyclooxygenase-2 promoter and uses thereof
06/26/2003WO2003051388A2 Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
06/26/2003WO2003051387A1 Remedies and/or preventives for conformational diseases
06/26/2003WO2003051383A2 Use of hmgb proteins and nucleic acids that code therefor
06/26/2003WO2003051309A2 Antisense modulation of abc transporter mhc 1 expression
06/26/2003WO2003051308A2 Antisense modulation of tfap2c expression
06/26/2003WO2003051305A2 Innate immune system-directed vaccines
06/26/2003WO2003051278A2 Nanoparticle delivery vehicle
06/26/2003WO2003051182A2 Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia
06/26/2003WO2003051180A2 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832
06/26/2003WO2003035678A3 Sperm factor sequences
06/26/2003WO2003033651A3 Compositions and methods for promoting nematode resistance in plants
06/26/2003WO2003029408A3 Esr2 - a plant gene that can promote plant regeneration and transformation
06/26/2003WO2003027310A3 Regulatable, catalytically active nucleic acids
06/26/2003WO2003026396A3 Transgenic mice containing socs-5 cytokine signalling suppressor gene disruptions
06/26/2003WO2003022306A3 Bacterial vaccine
06/26/2003WO2003020005A3 Lp mammalian proteins; related reagents
06/26/2003WO2003015702A3 Epitopes of human immunodeficiency virus-1
06/26/2003WO2003014153A8 Cellular virus receptors and methods of use.
06/26/2003WO2003004636A3 Expression vectors encoding bacteriophage signal peptides
06/26/2003WO2003000721A3 Mycobacterial antigens expressed under low oxygen tension
06/26/2003WO2002102855A3 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
06/26/2003WO2002094202A3 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
06/26/2003WO2002087606A3 Modulators of the hypocretin system and methods of screening therefor
06/26/2003WO2002081678A3 Method of separating alleles
06/26/2003WO2002070719A3 Regulatable gene expression system
06/26/2003WO2002070696A3 Cd109 nucleic acid molecules polypeptides and methods of use
06/26/2003WO2002069369A3 Cpg-like nucleic acids and methods of use thereof
06/26/2003WO2002066643A3 Proteins, polynucleotides encoding them and methods of using the same
06/26/2003WO2002064781A3 Regulation of amyloid precursor protein expression by modification of abc transporter expression or activity
06/26/2003WO2002064766A3 Bax-responsive genes for drug target identification in yeast and fungi
06/26/2003WO2002062977A3 Human phospholipase b-like polypeptide and uses thereof
06/26/2003WO2002061129A3 Oligonucleotide identifiers
06/26/2003WO2002060340A3 Method for identifying maxi-k channel blockers
1 ... 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 ... 4023